Abstract

SOLIDARITY’’ CLINICAL TRIAL OF COVID-19 TREATMENTS

*Salve Harshala D., Handore Ankita R., Dr. L. B. Borse and Dr. Anil G. Jadhav

ABSTRACT

In an unprecedented effort to obtain scientific data during the SARS-CoV-2 pandemic, the World Health Organization (WHO) has announced the new SOLIDARITY trial that would include thousands of patients from around the world (45 countries and counting), and which has been designed to be as simple as possible in order to encourage all hospitals with confirmed cases to participate. Although scientists have suggested various existing compounds for testing as potential therapeutic agents, the WHO will focus on the four most promising therapies: Remdesivir, chloroquine and hydroxychloroqunine, lopinavir and ritonavir, Interferon-Beta in combination with, lopinavir and ritonavir.

Keywords: COVID-19; chloroquine; hydrochloroquine; lopinavir; ritonavir; remdesivir; SARS-CoV-2.